R
Raffaele Cozzolongo
Researcher at University of Turin
Publications - 78
Citations - 1741
Raffaele Cozzolongo is an academic researcher from University of Turin. The author has contributed to research in topics: Ribavirin & Hepatitis C. The author has an hindex of 18, co-authored 66 publications receiving 1433 citations.
Papers
More filters
Journal ArticleDOI
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
Paolo Caraceni,Oliviero Riggio,Paolo Angeli,Carlo Alessandria,Sergio Neri,Francesco Giuseppe Foschi,F. Levantesi,Aldo Airoldi,S. Boccia,Gianluca Svegliati-Baroni,Stefano Fagiuoli,Roberto Giulio Romanelli,Raffaele Cozzolongo,Vito Di Marco,Vincenzo Sangiovanni,Filomena Morisco,Pierluigi Toniutto,Annalisa Tortora,Rosanna De Marco,Mario Angelico,Irene Cacciola,Gianfranco Elia,Alessandro Federico,Sara Massironi,Riccardo Guarisco,Alessandra Galioto,Giorgio Ballardini,Maria Rendina,Silvia Nardelli,Salvatore Piano,Chiara Elia,Loredana Prestianni,Federica Mirici Cappa,Lucia Cesarini,L. Simone,Chiara Pasquale,M. Cavallin,Alida Andrealli,F. Fidone,Matteo Ruggeri,A. Roncadori,Maurizio Baldassarre,Manuel Tufoni,Giacomo Zaccherini,Mauro Bernardi,Marco Domenicali,Ferdinando Giannone,Manuela Merli,Stefania Gioia,Silvano Fasolato,Antonietta Sticca,Daniela Campion,A. Risso,Giorgio Maria Saracco,D. Maiorca,Agostino Rizzotto,Arianna Lanzi,Elga Neri,Anna Visani,Antonio Mastroianni,A Alberti,Chiara Mazzarelli,Marcello Vangeli,Marco Marzioni,Francesca Capretti,Alba Kostandini,G. Magini,M. Colpani,Giacomo Laffi,T Gabbani,Maria Marsico,M. Zappimbulso,Josè Petruzzi,Vincenza Calvaruso,Giovanni Parrella,Nicola Caporaso,Francesco Auriemma,Maria Guarino,Fabio Pugliese,Antonio Gasbarrini,Pietro Leo,Francesco De Leonardis,A. Pecchioli,Piera Rossi,Giovanni Raimondo,Elisa Negri,Marcello Dallio,Carmelina Loguercio,Dario Conte,Natascia Celli,R. Bringiotti,N.M. Castellaneta,Francesco Salerno +92 more
TL;DR: Long-term HA administration prolongs overall survival and might act as a disease modifying treatment in patients with decompensated cirrhosis in this trial.
Journal ArticleDOI
Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial.
Alessandra Mangia,Nicola Minerva,D. Bacca,Raffaele Cozzolongo,G.L. Ricci,Vito Carretta,Francesco Vinelli,Gaetano Scotto,Giuseppe Montalto,Mario R. Romano,Giuseppe Cristofaro,Leonardo Mottola,Fulvio Spirito,Angelo Andriulli +13 more
TL;DR: Variable treatment duration ensures SVR rates similar to those of standard treatment duration, sparing unnecessary side effects and costs, according to HEPATOLOGY 2007.
Journal ArticleDOI
Changing pattern of chronic hepatitis D in Southern Europe
Floriano Rosina,P. Conoscitore,R. Cuppone,Giuseppe Rocca,Arcangela Patrizia Giuliani,Raffaele Cozzolongo,Grazia Anna Niro,Antonina Smedile,Giorgio Maria Saracco,Angelo Andriulli,O. G. Manghisi,Mario Rizzetto +11 more
TL;DR: Occurrence of fresh and severe forms of hepatitis D has diminished greatly in Italy and contemporary patients represent cohorts infected years ago who survived the immediate medical impact of hepatitis B and D viruses.
Journal ArticleDOI
Epidemiology of HCV Infection in the General Population: A Survey in a Southern Italian Town
Raffaele Cozzolongo,Alberto Rubén Osella,Silvana Elba,Josè Petruzzi,Giampiero Buongiorno,Vito Giannuzzi,Giuseppe Leone,Caterina Bonfiglio,Elsa Lanzilotta,O. G. Manghisi,Gioacchino Leandro +10 more
TL;DR: It is confirmed that HCV infection is clearly also declining in southern Italy, especially among the elderly, and age, blood transfusion, and household contact with HCV-infected individuals may have had a role in the spread ofHCV infection.
Journal ArticleDOI
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies
Velia Chiara Di Maio,Valeria Cento,Ilaria Lenci,Marianna Aragri,Piera Rossi,Silvia Barbaliscia,M. Melis,Gabriella Verucchi,Carlo Magni,Elisabetta Teti,Ada Bertoli,F.P. Antonucci,Maria Concetta Bellocchi,Valeria Micheli,C. Masetti,Simona Landonio,Simona Francioso,Francesco Santopaolo,Adriano M. Pellicelli,Vincenza Calvaruso,Laura Gianserra,Massimo Siciliano,Dante Romagnoli,Raffaele Cozzolongo,Antonio Grieco,Jacopo Vecchiet,Filomena Morisco,Manuela Merli,Giuseppina Brancaccio,Antonio Di Biagio,Elisabetta Loggi,Claudio Maria Mastroianni,Valeria Pace Palitti,Pierluigi Tarquini,Massimo Puoti,Gloria Taliani,Loredana Sarmati,Antonino Picciotto,Vincenzo Vullo,Nicola Caporaso,M. Paoloni,Caterina Pasquazzi,Giuliano Rizzardini,Giustino Parruti,Antonio Craxì,Sergio Babudieri,Massimo Andreoni,Mario Angelico,Carlo Federico Perno,Francesca Ceccherini-Silberstein +49 more
TL;DR: This study aimed to characterize the presence of clinically relevant RASs to all classes in real‐life DAA failures, and found that all classes of DAA patients had at least one RAS in their treatment regimens.